Department of Oncological Surgery, Veneto Oncological Institute (IOV-IRCCS), via Gattamelata 64, 35128, Padova, Italy.
J Gastrointest Surg. 2013 Feb;17(2):218-27. doi: 10.1007/s11605-012-2023-2. Epub 2012 Sep 13.
Esophageal adenocarcinoma is often associated with obesity, and a 5 Kg m(-2) increase in body mass index (BMI) has, in fact, been found to be strongly associated with the risk of this type of cancer (RR, 1.52; p < 0.0001). Esophagectomy with lymphoadenectomy is the mainstay of therapy for these patients. The aim of this study was to assess and compare the surgical and oncological outcomes as well as the survival rates of underweight, normal weight, overweight, and obese patients following esophagectomy for esophageal cancer.
Data relative to 1,127 patients with esophageal adenocarcinoma presenting at a specialized tertiary hospital (the Center of Esophageal Diseases for the Veneto Region) between 2000 and 2008 were prospectively collected. The 278 subjects whose BMI values before disease onset were available and underwent esophagectomy were enrolled in the study. Sixty-one of the 278 patients were classified as obese (BMI >30), 121 were classified as overweight (BMI, 25-29.9), 81 were classified as normal weight (BMI <24.9), and 15 ones as underweight (BMI <20). The outcome and survival of the four groups were compared. Frequency and survival analyses were carried out.
The rate of R0 esophagectomy and the incidence of toxicity during neoadjuvant chemotherapy were similar in the four groups. Respiratory complications after R0 esophagectomy seemed to be more frequent in the underweight and normal-weight patients group (p < 0.01). Moreover, underweight patients had a significantly higher rate of septic, cardiovascular, and metabolic postoperative complications. The 121 overweight patients had a better overall survival rate compared to normal weight and obese patients (p = 0.05). This difference was not significant if patients were stratified in stages I or II or stages III or IV.
Overweight patients seem to respond better to esophageal cancer and esophagectomy with respect to normal-weight ones. This data seem to suggest that in spite of several unfavorable features, a moderate increase of weight may be helpful to survive after esophagectomy for cancer.
食管腺癌通常与肥胖有关,实际上,体重指数(BMI)增加 5kg/m²与这种癌症的风险呈强相关(RR,1.52;p<0.0001)。食管腺癌患者的主要治疗方法是食管切除术加淋巴结清扫术。本研究旨在评估和比较超重、正常体重、超重和肥胖患者行食管癌切除术的手术和肿瘤学结果以及生存率。
前瞻性收集了 2000 年至 2008 年在一家专门的三级医院(威尼托地区食管疾病中心)就诊的 1127 例食管腺癌患者的数据。共纳入 278 例疾病发病前 BMI 值可用且行食管切除术的患者。278 例患者中,61 例肥胖(BMI>30),121 例超重(BMI,25-29.9),81 例正常体重(BMI<24.9),15 例消瘦(BMI<20)。比较了四组患者的预后和生存率。进行了频率和生存分析。
四组患者的 R0 食管切除术率和新辅助化疗期间毒性发生率相似。R0 食管切除术后的呼吸系统并发症在体重不足和正常体重患者组更为常见(p<0.01)。此外,体重不足的患者术后感染、心血管和代谢并发症的发生率明显较高。121 例超重患者的总生存率优于正常体重和肥胖患者(p=0.05)。如果将患者分层为 I 期或 II 期或 III 期或 IV 期,这种差异无统计学意义。
超重患者似乎比正常体重患者对食管癌和食管切除术的反应更好。这些数据表明,尽管存在多种不利特征,但适度增加体重可能有助于癌症患者行食管切除术后的生存。